
TG Fit 160mg Tablet
Marketer
Morepen Laboratories Ltd
Salt Composition
Fenofibrate (160mg)
Overview TG Fit 160mg Tablet
CholesteroGuard 160mg tablets effectively manage high cholesterol. This medication lowers triglycerides and low-density lipoprotein ("bad") cholesterol (LDL), simultaneously increasing high-density lipoprotein ("good") cholesterol (HDL). Reduced cholesterol levels significantly decrease the risk of stroke and heart attack. Adhere strictly to your doctor's prescribed dosage and regimen for CholesteroGuard 160mg tablets. It can be taken with food anytime, but consistency is key. High cholesterol often presents without symptoms; however, discontinuing treatment may worsen your condition, leading to elevated cholesterol and increased cardiovascular risk. Regular cholesterol monitoring is crucial. This medication forms part of a comprehensive treatment plan encompassing a balanced diet, regular physical activity, smoking cessation, controlled alcohol consumption, and weight management. Maintain a normal diet, minimizing high-fat foods. Common side effects include nausea, abdominal discomfort, diarrhea, and vomiting. Inform your physician of all current medications before starting CholesteroGuard 160mg. Caution is advised for individuals with liver or kidney disease. Pregnant or breastfeeding women should consult their doctor before use.
Uses of TG Fit 160mg Tablet
Elevated cholesterol and triglyceride levels
Major Benefits of TG Fit 160mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the 160mg TG Fit tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.
Common Side effects of TG Fit 160mg Tablet:
- Abdominal pain
- Diarrhea
- Nausea
- Headache
- Flatulence
- Vomiting
- Increased liver enzymes
- Increased creatine phosphokinase (CPK) level in blood
- Back pain
- Inflammation of the nose
How to use TG Fit 160mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The TG Fit 160mg Tablet should be administered with a meal.
How TG Fit 160mg Tablet works:
TG Fit 160mg tablets reduce elevated lipids. This medication lowers triglyceride and low-density lipoprotein (LDL, "bad") cholesterol concentrations, concurrently increasing high-density lipoprotein (HDL, "good") cholesterol.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside TG Fit 160mg Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of TG Fit 160mg tablets during pregnancy might pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Breastfeeding while taking TG Fit 160mg Tablets is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by TG Fit 160mg Tablets.
KidneyCAUTION
Individuals with kidney impairment should exercise caution when using TG Fit 160mg tablets, as dose modification may be necessary. Severe kidney disease contraindicates the use of TG Fit 160mg tablets; physician consultation is advised.
LiverUNSAFE
The use of TG Fit 160mg Tablets is contraindicated in patients with hepatic impairment and should be avoided. Individuals with severe liver disease should not take this medication. Medical advice is recommended.
What if you forget to take TG Fit 160mg Tablet :
Should you forget a TG Fit 160mg Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About TG Fit 160mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Fibric acid-based compound |
| Developing Habits | No. |
| Treatment Category | HEART |
| Actions | Fibrates (PPARα agonists) |
